HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.

AbstractAIM:
To compare the efficacy between dienogest and levonorgestrel-releasing intrauterine system (LNG-IUS) after laparoscopic surgery for endometriosis.
METHODS:
A total of 285 women were diagnosed as endometriosis by laparoscopy between 2011 and 2015. Patients were grouped into no treatment (n = 83), treatment with dienogest (n =130) and treatment with LNG-IUS (n =72) after laparoscopic surgery. The changes of the pain scores were checked at 6, 12 and 24 months after the surgery, and the rates of disease recurrence and treatment discontinuation rate were determined.
RESULTS:
The participants' mean age was 38.9 years (range 21-54 years). The mean age of LNG-IUS group (43.7 years) was significantly higher than the no treatment and dienogest groups (39.3 vs 33.9 years, respectively). At 6 and 12 months, the median pain scores in treatment (dienogest and LNG-IUS) groups were significantly lower than control group. Both treatment groups had significantly lower recurrence rate than control group (3.8% and 9.7%, respectively, vs 32.5%, P =0.001). No significant difference was found in the recurrence rate between the two treatment groups (P =0.461). Patients in the LNG-IUS group showed lower rate of discontinuation due to complication (27.8%) than those in dienogest group (35.6%, P =0.010).
CONCLUSION:
LNG-IUS treatment in the patients with endometriosis is effective for postoperative pain control and preventing recurrence, however, the LNG-IUS group is older, it is difficult to compare the efficacy between dienogest and LNG-IUS in present study.
AuthorsKi H Lee, Ye W Jung, Soo Y Song, Byung H Kang, Jung B Yang, Young B Ko, Mina Lee, Hye Y Han, Heon J Yoo
JournalThe journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 44 Issue 9 Pg. 1779-1786 (Sep 2018) ISSN: 1447-0756 [Electronic] Australia
PMID29974633 (Publication Type: Comparative Study, Journal Article)
Copyright© 2018 Japan Society of Obstetrics and Gynecology.
Chemical References
  • Contraceptive Agents, Female
  • dienogest
  • Levonorgestrel
  • Nandrolone
Topics
  • Adult
  • Contraceptive Agents, Female (administration & dosage, pharmacology)
  • Endometriosis (drug therapy, surgery, therapy)
  • Female
  • Humans
  • Intrauterine Devices, Medicated
  • Laparoscopy
  • Levonorgestrel (administration & dosage, pharmacology)
  • Middle Aged
  • Nandrolone (administration & dosage, analogs & derivatives, pharmacology)
  • Outcome Assessment, Health Care
  • Pain, Postoperative (drug therapy)
  • Pelvic Pain (drug therapy, surgery, therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: